---
schema_version: "secwatch.filing_event.v1"
accession: "0001411690-23-000022"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T08:43:17.094541+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bionano Q1 revenue $7.4M (+30% YoY); announces ~$20M cost reduction plan including layoffs

## Summary
- GAAP gross margin improved to 28% from 15% YoY; non-GAAP gross margin 30%.
- GAAP operating expense $39.9M; cash, equivalents and securities $95.8M (down from $113.2M).
- Installed base 259 Saphyr systems (+47% YoY); 5,226 flowcells sold (+62% YoY).
- Cost reduction initiative targets ~$20M savings over 4–5 quarters, includes workforce reduction effective May 8, 2023.

## SEC filing metadata
- accession: 0001411690-23-000022
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000141169023000022/0001411690-23-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000141169023000022/bngo-20230509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001411690-23-000022
- JSON: https://secwatch.observer/filing/0001411690-23-000022.json
- Plain text: https://secwatch.observer/filing/0001411690-23-000022.txt

## Key facts
- Earnings Releases
  Bionano Genomics, Inc. reported first quarter ended March 31, 2023 results: revenue $7.4 million.
  - Period: first quarter ended March 31, 2023
  - Revenue: $7.4 million
  - Result: reported results
  source text: Total revenue for the first quarter of 2023 was $7.4 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411690/000141169023000022/0001411690-23-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.